𝔖 Bobbio Scriptorium

✦ LIBER ✦

PCN191 Economic Evaluation of XELOX vs FOLFOX4 as Adjuvant Treatment for Patients with Stage III Colon Cancer in south Korea

✍ Scribed by Kim, C.M.; Ju, S.Y.; Kim, S.H.; Kang, M.; Park, J.; Choi, W.S.

Book ID: 122138023
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 57 KB
Volume: 14
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.08.1290

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN93 COST-MINIMIZATION ANALYSIS OF XELO

PCN93 COST-MINIMIZATION ANALYSIS OF XELOX (CAPECITABINE + OXALIPLATIN) VERSUS FOLFOX-4 (5-FU/LV + OXALIPLATIN) AS ADJUVANT TREATMENT IN STAGE III COLON CANCER UNDER THE BRAZILIAN PRIVATE PAYER PERSPECTIVE

✍ G Prolla; LG Borges; E Santos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

PCN94 CAPECITABINE + OXALIPLATIN (XELOX)

PCN94 CAPECITABINE + OXALIPLATIN (XELOX) VS. 5-FU/LV + OXALIPLATIN (FOLFOX4) IN THE ADJUVANT TREATMENT OF PATIENTS WITH COLON CANCER (ACC): COMPARISON OF DIRECT MEDICAL AND SOCIETAL (INDIRECT) COSTS

✍ R Winterhalder; G Delmore; M van Lier; A Urspruch; K Hieke 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

6010 A three-arm phase III randomized tr

6010 A three-arm phase III randomized trial of FOLFOX-4 vs. FOLFOX-4 plus bevacizumab vs. XELOX plus bevacizumab in the adjuvant treatment of patients with stage III or high-risk stage II colon cancer: results of the interim safety analysis of the AVANT trial

✍ Hoff, P.; Clarke, S.; Cunningham, D.; Van Cutsem, E.; Moore, M.; Schmoll, H.J.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

675 PUBLICATION Economic evaluation of c

675 PUBLICATION Economic evaluation of capecitabine (X) vs. bolus 5-FU/LV as adjuvant chemotherapy for patients (pts) with Dukes' C colon cancer in an Italian hospital setting

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

634 POSTER Post-study treatment does not

634 POSTER Post-study treatment does not influence outcome in the X-ACT phase III trial of capecitabine (X) vs. bolus 5-FU/LV as adjuvant therapy for patients (pts) with Dukes' C colon cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB